SKI Market

Indian Indices

Sensex

83,570.35 187.64
( 0.23%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,996.71 -113.79
(-0.21%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

41.5

819.7

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.22

Back

Leading Leasing Finance & Investment Company reports standalone net profit of Rs 1.70 crore in the September 2025 quarter

Nov 14,2025

Net profit of Leading Leasing Finance & Investment Company reported to Rs 1.70 crore in the quarter ended September 2025 as against net loss of Rs 0.23 crore during the previous quarter ended September 2024. Sales rose 73.01% to Rs 11.09 crore in the quarter ended September 2025 as against Rs 6.41 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	11.09	6.41	73
OPM %	97.20	83.31	-
PBDT	1.88	-0.22	LP
PBT	1.86	-0.23	LP
NP	1.70	-0.23	LP

83,570.35 187.64 ( 0.23%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,996.71 -113.79 (-0.21%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)